Gary L. Goldberg, MD
Vice Chair Department of Ob/Gyn, Director, Gynecologic Oncology
Albert Einstein College of Medicine/Montefiore Medical Center
Dept. of OB/GYN & Women's Health
1825 Eastchester Rd., Room 722
1825 Eastchester Rd., Room 722
Bronx,
NY
USA
10461
Papers:
100 - Featured Poster
Phase II trial of pemetrexed and carboplatin in platinum-sensitive recurrent ovarian, Fallopian tube, and primary peritoneal cancer
181 - Poster Session A
Malignant endometrial polyps in uterine serous carcinoma: does size matter?
192 - Poster Session A
Exome sequencing identifies germline mutations involving novel single nucleotide polymorphisms within DNA repair pathway genes in uterine serous carcinoma
198 - Poster Session A
Inhibition of chaperone-mediated autophagy may be a novel approach to increase platinum susceptibility in ovarian cancer cell lines
274 - Poster Session A
The PI3K inhibitor GDC-0941 is synergistic with lapatinib and mediates endocrine sensitivity in uterine papillary serous carcinoma via AKT
281 - Poster Session A
Expression of GPER, ERβ, ERα, and PR in gynecologic sarcomas
303 - Poster Session A
Radioimmunotherapy targeting human papillomavirus E7 oncoprotein demonstrates therapeutic potential and limited toxicity
314 - Poster Session A
Defining optimal combinations of PI3K/Akt/mTOR and Ras/Raf/MAPK pathway inhibitors for use in endometrial cancer
444 - Poster Session B
Prospective Phase II Trial of Adjuvant Pelvic Radiation “Sandwiched” Between Combination Paclitaxel/Carboplatin Chemotherapy in Women with Uterine Papillary Serous Carcinoma (UPSC)
524 - Poster Session B
Prevalence of cognitive impairment, pain, depression, and neuropathy in women with gynecologic malignancies